Christobel Selecky net worth and biography

Christobel Selecky Biography and Net Worth

Director of ImmunityBio

Christobel Selecky is a chief executive, entrepreneur and board member with more than 30 years of healthcare industry experience. Ms. Selecky held several leadership positions over her 14-year career at FHP International Corporation, including as President of the FHP California Health Plan. She subsequently co-founded, and served as President, CEO, and Executive Chairman of LifeMasters Supported SelfCare, a national leader in the field of disease and population health management. Ms. Selecky serves on corporate and not-for-profit boards of directors and, as a consultant helping improve patient engagement, population health outcomes, and healthcare cost management. In addition to ImmunityBio, she currently serves on the Boards of Directors of Paris-based Teleperformance, Satellite Healthcare, and Griswold Home Care. She is active in several board governance organizations such as NACD and Women Corporate Directors and is also a lecturer in Healthcare Entrepreneurship in the MBA program at the University of California, Irvine. Ms. Selecky joined the ImmunityBio Board in August 2020.

How do I contact Christobel Selecky?: The corporate mailing address for Selecky and other ImmunityBio executives is 3530 JOHN HOPKINS COURT, SAN DIEGO CA, 92121. ImmunityBio can also be reached via phone at (858) 633-0300 and via email at [email protected]. Learn More on Christobel Selecky's contact information.
Has Christobel Selecky been buying or selling shares of ImmunityBio?: Within the last three months, Christobel Selecky has sold $687,750.00 in shares of ImmunityBio stock. Most recently, Christobel Selecky sold 25,000 shares of the business's stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $10.00, for a transaction totalling $250,000.00. Learn More on Christobel Selecky's trading history.
Who are ImmunityBio's active insiders?: ImmunityBio's insider roster includes Richard Adcock (CEO), Michael Blaszyk (Director), Cheryl Cohen (Director), David Sachs (CFO), Christobel Selecky (Director), and Barry Simon (Director). Learn More on ImmunityBio's active insiders.
Are insiders buying or selling shares of ImmunityBio?: In the last year, insiders at the sold shares 7 times. They sold a total of 501,967 shares worth more than $4,466,412.40. The most recent insider tranaction occured on February, 24th when Director Barry J Simon sold 75,000 shares worth more than $900,750.00. Insiders at ImmunityBio own 69.5% of the company. Learn More about insider trades at ImmunityBio.
Information on this page was last updated on 2/24/2026.

Christobel Selecky Insider Trading History at ImmunityBio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
2/23/2026	Sell	25,000	$10.00	$250,000.00
1/20/2026	Sell	25,000	$7.51	$187,750.00
1/16/2026	Sell	50,000	$5.00	$250,000.00

Christobel Selecky Buying and Selling Activity at ImmunityBio

ImmunityBio Company Overview

ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Its platforms for the development of biologic product candidates include antibody-cytokine fusion proteins; DNA, RNA, and recombinant protein vaccines; and cell therapies. The company's platforms have generated therapeutic agents that are currently being or planned to be studied in clinical trials across various indications in liquid and solid tumors, including bladder, lung and colorectal cancers, and glioblastoma multiforme. Its lead biologic product candidate is Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute. It also has license agreements with 3M Innovative Properties Company; Access to Advanced Health Institute; LadRx Corporation; Sanford Health; Shenzhen Beike Biotechnology Co. Ltd.; Viracta Therapeutics, Inc.; and GlobeImmune, Inc. The company is based in San Diego, California.

Today's Range

Now: $9.37

$8.83

$9.65

50 Day Range

MA: $5.12

$1.98

$11.55

2 Week Range

Now: $9.37

$1.83

$12.43

Volume

14,996,221 shs

Average Volume

45,173,457 shs

Market Capitalization

$9.64 billion

P/E Ratio

N/A

Dividend Yield